Surrogate gene therapy for muscular dystrophy
An engineered truncated gene derived from the dystrophin-related protein (utrophin), prevents pathology without an immune response in an animal model of Duchenne muscular dystrophy (DMD) gene therapy.
Главные авторы: | Davies, KE, Chamberlain, JS |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Springer Nature
2019
|
Схожие документы
-
Therapeutic approaches to muscular dystrophy.
по: Goyenvalle, A, и др.
Опубликовано: (2011) -
The Pathogenesis and Therapy of Muscular Dystrophies
по: Guiraud, S, и др.
Опубликовано: (2015) -
Progress in therapy for Duchenne muscular dystrophy.
по: Fairclough, R, и др.
Опубликовано: (2011) -
Progress in therapy for Duchenne muscular dystrophy
по: Fairclough, R, и др.
Опубликовано: (2011) -
Utrophin in the therapy of Duchenne Muscular Dystrophy
по: Potter, A, и др.
Опубликовано: (2006)